Retroviral vector-mediated expression in primary human T cells of an endoplasmic reticulum-retained CD4 chimera inhibits human immunodeficiency virus type-1 replication

Human Gene Therapy
E San JoséB Alarcón

Abstract

Intracellular expression of genes that inhibit key steps in the human immunodeficiency virus (HIV-1) replicative cycle could offer an alternative therapy for AIDS treatment. One of these approaches involves the inhibition of env protein maturation through the expression of CD4 molecules with added exogenous sequences that promote their retention in the endoplasmic reticulum (ER). We have tested this strategy using a CD4 chimera (CD4epsilon10) containing an ER retention sequence derived from the TCR CD3-epsilon chain. Transfection of CD4epsilon10 in the human T cell line Jurkat made it resistant to infection with two different HIV-1 isolates, which was evaluated by measuring p24 antigen production, induction of apoptosis, and syncytia formation. Furthermore, polymerase chain reaction (PCR) analysis of genomic DNA showed no traces of the proviral HIV-1 genome in CD4epsilon10-transfected cells, suggesting it was not maintained latently in these cells. To facilitate the delivery of the CD4epsilon10 chimera to primary cells from AIDS patients, a Moloney-based retroviral vector was constructed that expresses CD4epsilon10 under the transcriptional control of the HIV-1 long terminal repeat (LTR) promoter. Transduction of the MT-2 human...Continue Reading

References

Oct 1, 1992·The Journal of Experimental Medicine·N K BandaT H Finkel
Feb 1, 1990·AIDS Research and Human Retroviruses·R A MorganW F Anderson
Aug 1, 1986·Molecular and Cellular Biology·A D Miller, C Buttimore
Nov 4, 1994·Gene·J E GeeM E Hogan
Apr 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·L Buonocore, J K Rose
Mar 1, 1993·AIDS Research and Human Retroviruses·M L GougeonL Montagnier

❮ Previous
Next ❯

Citations

Dec 24, 2005·Enfermedades infecciosas y microbiología clínica·Rafael Delgado, Benito J Regueiro
Mar 7, 2003·Gene Therapy·P CordelierD S Strayer
Apr 7, 2006·The Journal of Gene Medicine·Dorothee von LaerKlaus Hasselmann
Jun 26, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Irene ZaldívarEster San José

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.